Sage Open Medicine

Ayahuasca and cancer treatment

This review of case reports and biomedical literature proposes a molecular–cellular model — emphasising N,N‑dimethyltryptamine activity at intracellular sigma‑1 receptors and the effects of harmala alkaloids — to account for anecdotal tumour responses to ayahuasca, and concludes these reports may have plausible biological underpinnings that warrant further safety and efficacy research.

Published

October 21, 2013

Journal

Sage Open Medicine

Authors

Schenberg, E. E.